Large Cell Neuroendocrine Carcinoma of the Lung: Pathological Assessment and Differential Diagnoses of Neuroendocrine Carcinomas

Course Authors:
Fabio Tavora, MD
Callender-Binford Fellow, Department of Pulmonary and Mediastinal Pathology, Armed Forces Institute of Pathology, Washington, DC

Jeffrey R. Galvin, MD
Professor, Diagnostic Radiology, University of Maryland School of Medicine, Baltimore, Maryland, and Chief, Chest Imaging, Department of Radiologic Pathology, Armed Forces Institute of Pathology, Washington, DC

Teri J. Franks, MD
Chairman, Department of Pulmonary and Mediastinal Pathology, Armed Forces Institute of Pathology, Washington, DC

Upon completion of this activity, you will be able to:

• describe the histological features of large cell neuroendocrine carcinoma of the lung.
• list the histological criteria that define the neuroendocrine tumors of the lower respiratory tract, namely typical carcinoid, atypical carcinoid, large cell neuroendocrine carcinoma, and small cell carcinoma.
• discuss the treatment options for large cell neuroendocrine carcinoma and small cell carcinoma.

The ASCP is accredited by the ACCME to provide CME for physicians. The ASCP designates this educational activity for a maximum of 1 of AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ASCP designates this activity for a maximum of 1 CMLE credit. This activity meets CMP and state licensure requirements for laboratory personnel.